GA

Gaurav Agrawal

Active Director Director DIN 09706610
DIN 09706610 First appointment Aug 2022 Primary industry Real Estate
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Aug 2022
Shareholding value •••• Premium profile

About Gaurav Agrawal

Data last updated:

Gaurav Agrawal is a Director at Oxytocin Solutions Private Limited (since 2022), Managing Director at Covenant Advisories Private Limited (since 2023) and Director at Vamana Fintech Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Real Estate, BFSI and Transportation. The 4 current companies with reported revenue have a combined latest revenue of ₹12.03 Cr; the largest is Oxytocin Solutions Private Limited at ₹11.47 Cr (FY 2025).

DIN 09706610
Primary Designation Director
Industry Real Estate
First Appointment 18 Aug 2022
Oldest Company Age 4 yrs
Largest company Oxytocin Solutions Private Limited · ₹11.47 Cr (FY 2025)
Combined revenue ₹12.03 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oxytocin Solutions Private Limited U70109CT2022PTC013585
Director18 Aug 20222022₹11.47 Cr (FY 2025)Active
Covenant Advisories Private Limited U69100CT2023PTC015382
Managing Director09 Nov 20232023₹21.6 Lakh (FY 2025)Active
Vamana Fintech Private Limited U66190CT2023PTC014427
Director29 Mar 20252023₹17.9 Lakh (FY 2025)Active
Mayaru Productions Private Limited U60200CT2023PTC014880
Managing Director10 Jul 20232023₹16.4 Lakh (FY 2025)Active
Oxytocin Works Private Limited U52109CT2026PTC021231
Managing Director28 Sep 20262026Active
Celestria Global Council India U86900CT2025NPL019389
Managing Director29 Dec 20252025Inactive For E-Filing

Directorship timeline

Open interactive timeline →
Oxytocin Solutions Private Limited
Celestria Global Council India
Vamana Fintech Private Limited
Covenant Advisories Private Limited
Premium access

Shareholding and investment profile for Gaurav Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Agrawal

Gaurav Agrawal currently holds 6 directorships: Oxytocin Solutions Private Limited (Director, since 18 Aug 2022, revenue ₹11.47 Cr (FY 2025)); Covenant Advisories Private Limited (Managing Director, since 09 Nov 2023, revenue ₹21.6 Lakh (FY 2025)); Vamana Fintech Private Limited (Director, since 29 Mar 2025, revenue ₹17.9 Lakh (FY 2025)); Mayaru Productions Private Limited (Managing Director, since 10 Jul 2023, revenue ₹16.4 Lakh (FY 2025)); Oxytocin Works Private Limited (Managing Director, since 28 Sep 2026); and 1 more.

Gaurav Agrawal was first appointed on 18 Aug 2022 as Director at Oxytocin Solutions Private Limited. The most recent appointment on record is 28 Sep 2026 at Oxytocin Works Private Limited.

The 4 current companies of Gaurav Agrawal that report revenue have a combined latest revenue of ₹12.03 Cr: Oxytocin Solutions Private Limited ₹11.47 Cr (FY 2025); Covenant Advisories Private Limited ₹21.6 Lakh (FY 2025); Vamana Fintech Private Limited ₹17.9 Lakh (FY 2025); Mayaru Productions Private Limited ₹16.4 Lakh (FY 2025).

The current boards of Gaurav Agrawal's companies include Devyani Agrawal (Oxytocin Solutions Private Limited), Bhawna Pradhan (Covenant Advisories Private Limited), Niket Nayak (Mayaru Productions Private Limited), Gajendra Chourasia (Oxytocin Works Private Limited), Lukeshwar Sahu (Oxytocin Works Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available